GoHearing Ultra vs Lexie B3

The GoHearing Ultra is a budget-priced behind-the-ear OTC hearing aid that earns a B grade with a SoundScore of 3.1/5 in our lab testing. At $499, it sits in the most affordable price tier of the OTC market, though its overall sound performance ranks #58 of 65 devices in its category. In our testing, the Ultra shows a distinctive performance profile with significant strengths and weaknesses. Feedback handling is excellent at 5.0/5, scoring 0.46 points above the category average—users can expect stable operation without whistling during typical wear. Music streaming quality is also a genuine strength at 3.6/5, performing 1.68 points above average, making it notably better for phone audio than most OTC devices. However, speech clarity scores reveal meaningful limitations. Speech in quiet environments measured just 1.0/5, which is 1.79 points below the category average and low in absolute terms. Speech in noise similarly scored 1.0/5, falling 0.48 points below average. Own-voice comfort rated 1.9/5, also below the category norm. These results suggest the Ultra may struggle to deliver the speech audibility improvements that many users prioritize. The GoHearing Ultra may suit budget-conscious consumers who primarily want reliable streaming audio and feedback-free operation, and who have modest expectations for speech enhancement. However, several competitors in the same price range—including the Elehear Beyond and Apple AirPods Pro 2—deliver substantially stronger overall sound performance. Users prioritizing speech clarity should consider these alternatives despite similar pricing.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.